Iwosan Investments Limited, a pioneering healthcare investment holding company, recently announced the acquisition of Euracare Multi-specialist Hospital in Victoria Island, Lagos. This strategic move strengthens Iwosan’s commitment to delivering exceptional healthcare services and expanding access to specialised medical care in Nigeria.
Established in 2019, Iwosan has consistently invested in critical healthcare infrastructure across the country. The company’s mission is rooted in the belief that a thriving society depends on a robust healthcare system—one that prioritizes quality, accessibility, and innovation.
Euracare, renowned for its expertise in specialist medical services such as cardiology, neurology, oncology, and advanced diagnostic imaging, complements Iwosan’s vision of creating a network of healthcare excellence. The partnership promises to enhance patient outcomes, introduce cutting-edge medical technologies, and offer Nigerians more opportunities for advanced care locally.
Tosin Majekodunmi, medical director and interim CEO of Euracare, in this interview with Josephine Okojie-Okeiyi, spoke on how this acquisition aligns with Iwosan’s broader vision, the strategic roadmap for scaling healthcare innovation, and what this development means for the future of specialised medical care in Nigeria.
Firstly, congratulations on the acquisition. From your perspective, having been the medical director at Euracare, what factors do you believe made your hospital an attractive investment for Iwosan Investments?
Euracare commenced operations in 2017 and, in a very short space of time, developed a reputation for excellence and innovation in healthcare provision.
Despite challenges such as the COVID-19 pandemic, currency fluctuations, and inflationary pressures, we have continued to deliver world-class care across our specialities.
This acquisition represents an opportunity to build on our strong foundation, expand specialised service offerings, and integrate new technologies to further enhance patient care.
I believe these qualities made it an appealing prospect for Iwosan Investments Limited, given our uncommon commitment to delivering exceptional quality care through cutting-edge facilities and innovative practices.
Additionally, Euracare’s track record in pioneering advanced procedures and providing services across more than 20 diagnostic and interventional specialists positioned us as a leader in healthcare quality and safety.
Our alignment with Iwosan’s vision—strengthening healthcare infrastructure and investing in healthcare talent—makes this partnership a natural progression.
Joining the Iwosan Group enables us to benefit from a supportive network focused on governance, operations, and comprehensive healthcare delivery, ultimately allowing us to deepen our impact and consistently prioritise patient needs while maintaining our identity as a centre of medical excellence in Nigeria.
Can you describe the immediate priorities for both hospitals, particularly in ensuring a smooth transition for patients and staff in Lagos?
Our top priority is ensuring that our patients and staff remain confident in the quality of care we provide. Our commitment to excellence hasn’t changed, and neither have the services our patients rely on.
With Iwosan’s acquisition of Euracare, we are strengthening clinical expertise, expanding service offerings, and enhancing operational efficiency to improve patient outcomes.
We are resolute that Euracare patients will continue receiving world-class medical care. The future of healthcare is evolving, and we’re evolving with it—while staying true to what matters most: delivering exceptional care.
Many patients and staff may be concerned about potential disruptions to services. Can you address these concerns and explain the plans to maintain continuity of care?
I want to take a moment to reassure our patients, staff, and stakeholders that ensuring service continuity remains our highest priority.
Throughout the acquisition and due diligence process, we have worked closely to maintain continuity—keeping key personnel in place, ensuring smooth operations, and upholding the quality of care that our patients expect.
Our services will continue without disruption, and there will be no immediate changes to how we operate. Our dedicated medical teams remain fully committed to delivering uninterrupted care.
Over time, we will introduce thoughtful enhancements that further strengthen patient experience, infrastructure, and clinical expertise.
As the medical director and interim CEO, what specific measures are you implementing to leverage the benefits of this acquisition toward enhancing Euracare’s range of services and capabilities?
This acquisition marks the beginning of an exciting new phase for Euracare. We are proud to be recognised as one of Nigeria’s premier healthcare facilities, known for delivering world-class standards of care across multiple specialities.
With the support of Iwosan Group, we are now better positioned to expand our multi-specialist services and enhance our capabilities by leveraging cutting-edge technology and innovative practices.
The integration with Iwosan provides access to comprehensive support in the form of governance, finance, operations, human resources, and administration.
This collaboration fosters knowledge exchange and best practices, allowing us to further strengthen our clinical excellence and patient outcomes.
Ultimately, this partnership enables us to deepen our impact, extend our reach within the community, and reaffirm our commitment to consistently prioritising the needs of our patients.
Euracare has built a reputation for its specialised services. How do you believe your hospital will continue to ensure that these services are not only maintained but potentially enhanced for patients in the region?
This question addresses the crux of why we are so excited by the investment opportunities unlocked through this acquisition.
Advancements in medical technology are accelerating, and staying ahead requires continuous investment in both talent and infrastructure.
With Iwosan’s backing, we are well-positioned to enhance our capabilities, ensuring we not only sustain our high standards but also push the boundaries of healthcare delivery in Nigeria.
Euracare’s integration into the Iwosan Group provides access to shared resources, expertise, and comprehensive support in governance, finance, operations, human resources, and administration, which strengthens our capacity to deliver exceptional patient care.
By leveraging Iwosan’s proven track record of successful investment in healthcare, Euracare will be able to broaden its service offerings and maintain its leadership as a centre of medical excellence in Nigeria.
Will Iwosan brands such as Euracare and Iwosan Lagoon Hospitals continue to operate as independent brands, or will they be merged?
This has been one of the most common questions since the acquisition. Iwosan Lagoon hospitals have been in existence for many years in the Lagos area and have developed their renowned reputation for healthcare delivery, while Euracare is a relatively new entrant to the healthcare landscape in Lagos.
Both organisations shall remain completely independent brands, focusing on their unique services to continue to deliver the best possible healthcare to patients.
Looking ahead, what do you think are the most exciting opportunities that this acquisition presents for patients seeking quality healthcare in Lagos and Nigeria as a whole?
I believe the most exciting opportunity is the chance to expand access to high-quality healthcare for more people in Lagos and across Nigeria.
This acquisition allows us to build on Euracare Multi-Specialist Hospital’s strong foundation, integrating it into Iwosan’s growing network of healthcare facilities.
With Iwosan’s commitment to investing in healthcare infrastructure, advanced technology, and specialised expertise, we can enhance service offerings, pioneer cutting-edge procedures, and strengthen medical excellence in Nigeria.
This will not only improve patient outcomes but also reduce the need for Nigerians to seek treatment abroad. Over time, I am confident this will drive positive change across the healthcare landscape, ensuring more people receive world-class care closer to home.
